Opko Health, Inc.

298 articles with Opko Health, Inc.

• Opko Health, Inc. Acquires Biotechnology Company with Unique Platform Technology to Develop New Drugs

  2/1/2011

• Opko Health, Inc. to Partner with Bristol-Myers Squibb Company on Blood Test for Alzheimer's Disease

  1/14/2011

• Opko Health, Inc. Announces Publication on Technology Underlying Blood Test for Alzheimer’s Disease

  1/7/2011

• Tesaro, Inc. and Opko Health, Inc. Sign Exclusive License Agreement for Rolapitant

  12/14/2010

• Opko Health, Inc. to Present at UBS Global Life Sciences Conference

  9/20/2010

• Opko Health, Inc. to Present at Jefferies 2010 Global Life Sciences Conference

  6/4/2010

• Opko Health, Inc. Announces Collaboration with Mexican Research Center

  2/22/2010

• Opko Health, Inc. Acquires Mexican Pharmaceutical Company, Pharmacos Exakta, S.A. de C.V.

  2/18/2010

• Opko Health, Inc. to Present at the Lazard Capital Markets 6th Annual Healthcare Conference

  11/16/2009

• Opko Health, Inc. Completes Acquisition of NK-1 Compounds from Schering Corporation

  11/11/2009

• Opko Health, Inc. Acquires Lead NK-1 Compounds from Schering-Plough Corporation

  10/13/2009

• Opko Health, Inc. Acquires Chilean Pharmaceutical Company, Pharma Genexx S.A. for US $16 Million

  10/2/2009

• Opko Health, Inc. Acquires New Platform Technology

  6/17/2009

• Opko Health, Inc. Invests in Biotechnology Company with Novel Approach to Developing New Drugs

  6/15/2009

• Opko Health, Inc. Invests in Biotechnology Company Sorrento Therapeutics, Inc. Developing Human Antibody Library

  6/11/2009

• Opko Health, Inc. Announces Update on Phase III Clinical Trial of Bevasiranib; Company Decided to Terminate Clinical Study

  3/6/2009

• Opko Health, Inc. To Present Data on Next Generation Anti-Angiogenic VEGF165b-Sparing siRNA at Association for Research in Vision & Ophthalmology (ARVO 2009) Meeting

  2/10/2009

• Opko Health, Inc. Receives FDA 510(k) Clearance for Spectral OCT SLO Combination Imaging System

  1/23/2009

• Opko Health, Inc. Initiates Clinical Trial of the Aquashunt(TM) to Treat Glaucoma

  1/22/2009

• Opko Health, Inc. Announces Completion of Enrollment for Its Phase III Clinical Trial of Bevasiranib for Treatment of AMD

  12/4/2008